(MedPage Today) — An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using continuous glucose monitoring (CGM), a randomized trial showed.
Over 13 weeks, drops in HbA1c averaged…
Source link : https://www.medpagetoday.com/endocrinology/diabetes/114738
Author :
Publish date : 2025-03-19 21:20:00
Copyright for syndicated content belongs to the linked Source.
